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1 |  INTRODUCTION
Differentiating between epileptic seizures (ES) and psy-
chogenic nonepileptic seizures (PNES) is a commonly en-
countered problem for neurologists. The symptoms of these 
2 diseases can be difficult to differentiate, especially in the 
emergency department (ED) setting, where patients often pre-
sent following their events without clear witnessed history. 
This limitation can lead to a tendency to treat the patients as 
though they had ES. Studies have shown that patients often 
get misdiagnosed, with a mean PNES diagnosis delay of 
7.2 years.1 The estimated lifetime cost of PNES misdiagno-
sis was appreciated as $100 000 per patient, and the annual 
cost of PNES misdiagnosed as ES can be estimated between 
$650 million and $4 billion in the United States.2
In this study, we explored whether the combination of 
transient leukocytosis and acidosis could help to differentiate 
these 2 clinically similar but pathophysiologically different 
diseases in the ED setting, by analyzing the complete blood 
(cell) count (CBC) and anion gap (AG).
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Summary
Epileptic seizures (ES) and psychogenic nonepileptic seizures (PNES) can be diffi-
cult to differentiate from each other in the emergency department (ED) setting. We 
have previously shown that the anion gap (AG) can help differentiate between ES 
and PNES in the ED. In this study, we explored whether additionally considering 
leukocytosis can help better differentiate between ES and PNES. We screened a total 
of 1354 subjects seen in the ED of a tertiary care medical center; 27 PNES and 27 ES 
patients were identified based on clinical description and subsequent electroencepha-
lography (EEG). Multivariable logistic regression analysis was used to model the 
association between ES, leukocytosis, and AG. Our results indicated that within 
9 hours after the index event, serum AG (adjusted odds ratio [aOR] 2.07) and white 
blood cell (WBC) count (aOR 1.61) were both independently associated with ES. 
We derived an equation to help differentiate between ES and PNES: 1.5*AG+WBC. 
A score >24.8 indicated a >90% likelihood of ES. A score <15.5 indicated a <10% 
likelihood of ES (ie, the alternate diagnosis of PNES should be considered). This 
study for the first time provides evidence to help differentiate PNES and ES utilizing 
acidosis and leukocytosis.
K E Y W O R D S
acidosis, anion gap, leukocytosis, nonepileptic seizure, seizure
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2 |  METHODS
2.1 | Study design and selection criteria
This study was conducted with a retrospective chart re-
view on patients who visited a tertiary care medical center 
emergency room (University of Massachusetts Memorial 
Hospital, Worcester, MA) between January 1, 2014 and June 
30, 2016. The study was performed with approval and in ac-
cordance with the guidelines of the institutional review board 
(H00010215) at the University of Massachusetts Medical 
School.
The patient cohort with inclusion and exclusion criteria 
has been described previously.3 The inclusion criteria were 
the following: (a) ED diagnosis of “generalized seizures,” 
“generalized shaking episodes,” or “seizures” for adult pa-
tients older than 18; and (b) a well- documented spell onset 
within 24 hours of a basic metabolic panel (BMP) and 
CBC obtained in the ED. The exclusion criteria were the 
following: (a) patients had other documented active medi-
cal problems that could cause acidosis or leukocytosis, and 
confound the analysis, such as sepsis, alcohol, or medicine 
toxicity; and (b) patients who were taking medications that 
could cause metabolic acidosis (such as topiramate, zonis-
amide, hydrochlorothiazide, acetaminophen, diuretics, and 
steroids) were excluded unless they had a baseline normal 
BMP within the 12 weeks preceding their presentation on the 
same medications.
Patients were subsequently assigned to ES and PNES 
groups. All the patients included in the ES group had (a) 
documented semiology of the event that was consistent with 
a generalized convulsive seizure; (b) an abnormal interictal 
electroencephalography (EEG) showing epileptiform dis-
charges; and (c) did not have repetitive seizures that occurred 
within 6 hours to avoid the potential influence of the repeti-
tive episodes on the study analysis. All the patients included 
in the PNES group had spells with “generalized body jerk-
ing” and had subsequent video- EEG capturing similar events 
confirming the diagnosis of PNES. The PNES patients with 
semiology of non- motor symptoms were excluded.
2.2 | Statistical analysis
The continuous variables are reported as mean ± standard 
deviation (SD). Between- group comparisons for continu-
ous variables were made with Student t test. Multivariable 
logistic regression analysis, receiver- operator characteristic 
(ROC) curves, and Hosmer- Lemeshow goodness- of- fit test 
were used to investigate the association between the prob-
ability of AG, white blood cell (WBC) counts, and probabil-
ity of having ES. Once an adjusted logistic regression model 
was fit, the estimated coefficients were used to create a lin-
ear equation to predict the probability, >90% and <10%, of 
having ES. An alpha level of 0.05 was considered to assess 
statistical significance. SAS 9.4 (SAS Institute Inc., Cary, 
NC) was used for statistical analysis.
3 |  RESULTS
3.1 | Demographic and clinical 
characteristics
Among the total screened 1354 patients, 126 met inclusion 
criteria. Of these, 72 were excluded because they had other 
medical conditions, toxicities, or chronic medications that 
could cause metabolic acidosis. Of the remaining 54 patients, 
enough medical record information was available to stratify 
27 to the ES group and 27 to the PNES group. There were 
no significant differences in gender or mean age between 
the group of PNES and ES patients (Table S1). Antiepileptic 
medications used by the patients in the final cohort included 
levetiracetam, zonisamide, valproic acid, gabapentin, pheny-
toin, oxcarbazepine, lorazepam, and diazepam.
3.2 | Dynamic changes of 
leukocytosis and acid- base equilibrium in the 
ES vs PNES patients
As shown in Table 1, subjects were grouped based on the 
time between the event and the collection of blood to evaluate 
the effect of time on the ability of these values to differentiate 
between ES and PNES. The mean AG was elevated in the ES 
Key Points
• Differentiating between ES and PNES is a com-
monly encountered issue for neurologists
• The mean AG was elevated in the ES group within 
the first hour until the 24-hour period after the 
event, when compared to the PNES group 
(P < 0.05)
• Elevation of WBC count was also observed in the 
ES group when compared to the PNES group, 
with significant differences seen starting 2 hours 
after the event (P < 0.05)
• The area under the curve (AUC), sensitivity, and 
negative predictive value of AG and WBC count 
to differentiate ES from PNES decreased as time 
progressed
• An equation was derived for patients who had an 
index event within 9 hours: 1.5*AG+WBC; a 
score >24.8 indicates a >90% likelihood of ES
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group compared to the PNES group from as early as within the 
first hour until the 24- hour period after the event (P < 0.05). 
Elevation of WBC count was also observed in the ES group 
when compared to the PNES group, with significant differences 
seen starting at a later time (2 hours after the event) and persist-
ing until 24 hours (P < 0.05, separately).
3.3 | Efficacy of transient leukocytosis and 
AG changes to help differentiate PNES 
from ES
The ROC curve for sensitivity and specificity of ES detection 
was plotted for AG and WBC count. Areas under the ROC 
curve (AUC) within 24 hours were 0.822 and 0.688, respec-
tively (Figure S1). The AUC, sensitivity, and negative predic-
tive value decreased as time progressed (Figure S2).
3.4 | A model of utilizing WBC count and 
AG to help differentiate between ES and PNES
Multivariable logistic regression analysis was used to model 
the association of probability of having ES using both vari-
ables of WBC count and AG at different durations up to 
24 hours. At the time interval beyond 12 hours between 
the spell and the blood draw, the sensitivity of WBC count 
dropped out and did not contribute to the model in a statis-
tically significant manner. When modeled using logistic re-
gression with a cutoff of 9 hours, serum AG (adjusted odds 
ratio [aOR] 2.07) and WBC count (aOR 1.61) were both 
independently associated with ES. By defining the prob-
ability of high (>90%), intermediate (10%- 90%), and low 
(<10%), we derived a score to help predict a patient's like-
lihood of having ES vs PNES based on the AG and WBC 
counts. When 1.5*AG+WBC is >24.8, the patient has a high 
likelihood of ES; whereas when 1.5*AG+WBC is <15.5, the 
patient has a low likelihood of ES, hence the alternate diag-
nosis of PNES should be considered (Figure 1).
4 |  DISCUSSION
Our study suggests that the dynamic changes of leukocyto-
sis and acid- base disequilibrium could be used to help dif-
ferentiate between ES and PNES. The first of these changes 
was anion gap (or AG) elevation. Transient leukocytosis is 
not a sensitive but specific marker to different between ES 
and PNES. By using these 2 markers, we proposed a score to 
help evaluate whether the patients with a generalized shaking 
event had a high or low likelihood of ES.
In this present study, we demonstrated that the transient 
leukocytosis associated with ES persisted up to 9 hours 
after the event, but not in the PNES group. The possible 
pathophysiologic mechanism of seizure- related leukocyto-
sis could be demargination of deposited leukocytes caused 
by high levels of catecholamines.4 Previous studies have 
shown that the incidence of leukocytosis after generalized 
seizures was variable at around 30%- 62.5% using different 
time cutoffs,4–6 which was consistent with our finding that 
F I G U R E  1  The association of ES, WBC count, and anion gap in the first 9 hours after the event with multivariable regression modeling. The 
ROC of the modeling was 0.925. A, Serum AG (adjusted odds ratio 2.07, 95% CI 1.17- 3.67) and WBC count (adjusted odds ratio 1.61, 95% CI 
1.07- 2.42) were both independently associated with ES. B, Hosmer- Lemeshow goodness- of- fit test P- value for this modeling was 0.77, leading us 
to conclude that there is no evidence that the model does not fit the data. The C- statistic was 0.93, indicating the model has good discrimination
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leukocytosis is not a highly sensitive, but rather a specific 
biomarker for ES vs PNES (Figure S2). Transient leuko-
cytosis is a well- known phenomenon after exercise and 
is determined mainly by the intensity and duration of the 
physical exertion. Although the PNES patients in this co-
hort were reported to have generalized body shaking, we 
suspect that their activity was less intense than that of the 
generalized tonic- clonic seizures in the ES group, and that 
the intensity of this physical stress was inadequate to in-
duce leukocytosis.
In addition, the time that elapsed since the shaking spell 
is also vital for the dynamic changes of both leukocytosis 
and AG level. Acidosis occurs within 1 hour after ES and ap-
pears in a very transient pattern as we reported previously.3 
The phenomenon of leukocytosis, defined as increased 
WBC count (the normal range of WBC is 4.0- 10.4 × 103/
μL in our study cohort), can be seen in various situations 
such as inflammation, inflammatory diseases, and stress. 
When we compared the mean value of WBC count in the 
2 different groups, it showed significant difference between 
ES and PNES with a slight lag from 2 hours to 9 hours after 
the event, and soon resolved beyond this period in our study. 
Similar dynamic leukocytosis response has been reported 
after strenuous exercise with a peak time of 2- 4 hours af-
terward.7 There have been proposals that it could be due 
to catecholamines produced during exercise, which act to 
increase the ratio of circulating to noncirculating leuko-
cytes, and cortisol, which involves a time lag to increase 
the total number of leukocytes in the vascular compartment. 
Although our data did not show a significant difference of 
WBC counts between these 2 groups within the first hour, 
the limits of our sample size may not capture the significant 
difference that was noted in later time points with a larger 
sample size.
Other studies have tried to investigate potential bio-
markers to help identify ES from other alternative di-
agnosis, such as prolactin level, serum lactate level, 
hormone changes, as well as postictal ammonia. Each 
of these also has their own merits and disadvantages. 
Prolactin level was also elevated after PNES,8 and the 
pattern of changes varies if patients have repetitive sei-
zures.9 Ammonia and lactate required narrow time win-
dows (<1 hour, and 2 hours, respectively) to observe the 
changes.10,11 The biomarkers proposed in our study allow 
longer duration between the event and the time of blood 
being drawn, and they are routinely drawn in this set-
ting, which usually has a rapid turn- around, and hence 
are more practical in daily practice. Recent studies have 
shown that surface electromyography might help distin-
guish between convulsive PNES and ES.12 In addition, 
a scoring system of clinical history and comorbidities 
has been proposed to diagnosis PNES, which achieved 
promising results.13,14 Further studies of investigating the 
combination of the preceding methods and the concomi-
tant AG and WBC cell biomarker changes for increasing 
the accuracy of determination of PNES vs ES would be 
interesting to pursue.
Our study also has limitations. All the subjects recruited 
in the ES group had described semiology consistent with 
a generalized convulsive seizure and an EEG observation 
of at least interictal epileptiform discharges, but no ictal 
video- EEG was obtained in these subjects due to the ret-
rospective limitations of the study. Similarly, the shaking 
spell in patients in the PNES group patients before ED ad-
mission was not recorded in real- time with video- EEG, but 
similar events with same description of semiology were 
identified with subsequent video- EEG to confirm their 
diagnoses. Although the patients in the PNES group had 
similar semiology, with their index events identified and 
diagnosed by video- EEG, it is possible that some patients 
may have had a mixed ES and PNES disorder. In addition, 
the overall sample size is moderate. Although our study 
does show a significant difference between the 2 groups 
(generalized tonic clonic seizures vs PNES) and the regres-
sion model does fit the data well, future prospective studies 
with larger sample size are warranted for further validation.
In summary, the tool of 1.5*AG+WBC proposed in the 
current study could be helpful as another piece of evidence 
for diagnostic consideration when confronted with this com-
mon situation in the emergency setting.
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